XML 47 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues      
Total revenues $ 302,328 $ 257,654 $ 209,625
Cost and expenses      
Research and development 51,357 51,355 50,064
Selling, general and administrative 206,176 154,872 155,306
Gain from disposal of business (14,388)    
Total cost and expenses 418,615 372,282 344,966
(Loss) income from operations (116,287) (114,628) (135,341)
Interest expense (10,693) (10,476) (4,213)
Interest and other (expense) income, net 4,152 (2,729) 2,380
Loss before income taxes (122,828) (127,833) (137,174)
Income tax expense (1,999) (321) (454)
Net loss (124,827) (128,154) (137,628)
Unrealized gain (loss) on available-for-sale securities, net of tax 1,471 214 (41)
Comprehensive loss $ (123,356) $ (127,940) $ (137,669)
Net loss per share (Note 15):      
Basic (in dollars per share) $ (1.79) $ (2.22) $ (2.58)
Diluted (in dollars per share) $ (1.79) $ (2.22) $ (2.59)
Weighted-average number of shares used in computing basic and diluted net loss per share:      
Basic (in shares) 69,555 57,848 53,312
Diluted (in shares) 69,555 57,848 53,604
Product      
Revenues      
Total revenues $ 269,881 $ 240,366 $ 203,777
Cost and expenses      
Cost of revenues 162,604 158,081 135,508
Licensing and other      
Revenues      
Total revenues 32,447 17,288 5,848
Cost and expenses      
Cost of revenues $ 12,866 $ 7,974 $ 4,088